Drug residues in used syringes in selected European cities, 2019

Graphic showing location of sites (Glasgow, Amsterdam, Paris, Lausanne, Budapest, Helsinki) for the 2017 pilot study of the ESCAPE (European Syringe Collection and Analysis Project Enterprise) project.

Originally published in:

European Drug Report 2020: Trends and Developments
Figure 31

Main subject

prevalence and patterns of drug use

Keywords

amphetamine
cannabis
cocaine
ESCAPE
heroin
injecting drug use
prevalence and patterns of drug use
synthetic cathinones

Target audience

general public
researcher

Media type:

infographics

Published date:

September 2020
CC-BY-4.0
Download (0.3 MB)

Related assets in the Media library

screenshot from video
EMCDDA webinar recording: How wastewater monitoring can boost preparedness for new health threats
Cannabis users are the most likely to report using more than one drug other than their primary drug, followed by opioids and cocaine users.
Infographic: polydrug use among clients entering treatment by primary drug in the EU-27, Norway and Turkey, 2020
Map showing estimates of prevalence of high risk opioid use in Europe. Rates range from below 1 to around 8 per 1000.
Last year prevalence of high-risk opioid use among adults in Europe
Graphic shows a series of pie charts for cannabis, cocaine, MDMA and amphetamines, showing drug prevalance rates in the EU. Cannabis is the most used drug with 7.7% of adults having used it in the last year. Last year use for cocaine is 1.2%, MDMA is 0.9%
At a glance — estimates of drug use in the European Union (updated June 2022)
Infographics: Changes in the mean weekly amounts of methamphetamine residues from wastewater analyses in selected European cities between 2019 and 2020
Infograpic: Proportion of all amphetamine samples submitted for testing to drug-checking services containing only the expected substance (amphetamine) in nine European cities in 2019 and 2020

Media library

Loading